All

What are you looking for?

All
Projects
Results
Organizations

Quick search

  • Projects supported by TA ČR
  • Excellent projects
  • Projects with the highest public support
  • Current projects

Smart search

  • That is how I find a specific +word
  • That is how I leave the -word out of the results
  • “That is how I can find the whole phrase”
EN
ČeštinaEnglish

Filters

4 534 (0,127s) •

Project

Next generation sequencing for early diagnosis and individualized treatment of dilated cardiomyopathy and related forms of cardiomyopathy (NV15-27682A)

stratification could improve allocation of expensive methods of non-pharmacologic treatment...

FA - Kardiovaskulární nemoci včetně kardiochirurgie

  • 2015 - 2019
    • •
  • 17 870 tis. Kč
    • •
  • 17 766 tis. Kč
    • •
  • MZ
Project

Familial hypertrophic cardiomyopathy detection of mutations in exon 13 of the beta-myosin heavy chain. (IZ2971)

FA - Kardiovaskulární nemoci včetně kardiochirurgie

  • 1995 - 1997
    • •
  • 771 tis. Kč
    • •
  • 723 tis. Kč
    • •
  • MZ
Project

Genetic Determination of Dilated Cardiomyopathy (IZ3078)

FA - Kardiovaskulární nemoci včetně kardiochirurgie

  • 1995 - 1997
    • •
  • 899 tis. Kč
    • •
  • 873 tis. Kč
    • •
  • MZ
Project

ACE inhibitors - a new mode of therapy of hypertrophic nonobstructive cardiomyopathy. (IZ1901)

9F - 9

  • 1994 - 1996
    • •
  • 636 tis. Kč
    • •
  • 977 tis. Kč
    • •
  • MZ
Project

Pathophysiologic mechanisms, nutritional and pharmacological treatment of cardiomyopathy in renal insufficiency. (IZ2023)

9F - 9

  • 1994 - 1996
    • •
  • 569 tis. Kč
    • •
  • 821 tis. Kč
    • •
  • MZ
Project

Late potentials and their changes in time - possible marker of progression of fibrotic changes in myocardium. (IZ2942)

9F - 9

  • 1995 - 1996
    • •
  • 51 tis. Kč
    • •
  • 51 tis. Kč
    • •
  • MZ
Project

Proteomic analysis of the potential markers in patients with dilated cardiomyopathy (NV19-02-00297)

in the proposed project we plan to employ state of art non-gel proteomic analysis can early distinguish patients responding or non-responding to standard therapy......

Cardiac and Cardiovascular systems

  • 2019 - 2023
    • •
  • 9 343 tis. Kč
    • •
  • 9 343 tis. Kč
    • •
  • MZ
Project

Clinical and proteomic biomarkers for prediction of left ventricle reverse remodeling in patients with recent onset dilatated cardiomyopathy (NU22-02-00418)

is endomyocardial biopsy (EMB). The benefit of non-invasive imaging methods is less convincing tool for non-invasive myocarditis detection and thus may lead to the reduction......

Cardiac and Cardiovascular systems

  • 2022 - 2025
    • •
  • 8 031 tis. Kč
    • •
  • 8 031 tis. Kč
    • •
  • MZ
Project

Next generation sequencing for early diagnosis and individualized therapy of hypertrophic cardiomyopathy (NV15-34904A)

Cardiomyopathies (CMP) are a heterogeneous group of diseases with impaired cardiac structure and/or function, which represent an important cause of cardiovascular morbidity and mortality, and are often hereditary. Hypertrophic cardiomyopathy is the m...

FA - Kardiovaskulární nemoci včetně kardiochirurgie

  • 2015 - 2018
    • •
  • 11 717 tis. Kč
    • •
  • 11 717 tis. Kč
    • •
  • MZ
Project

Prototype - Innovative tester for automated testing of a dual-chamber external pacemaker (EI22_002/0001052)

způsobem, kdy se bude jednat o kompaktní, uzavřený celek, do kterého bude...

Computer sciences, information science, bioinformathics (hardware development to be 2.2, social aspect to be 5.8)

  • 2024 - 2026
    • •
  • 11 889 tis. Kč
    • •
  • 0 tis. Kč
    • •
  • MPO
  • 1 - 10 out of 4 534